Soluble epoxide hydrolase inhibition Promotes White Matter Integrity and Long-Term Functional Recovery after chronic

Yuxue Chen1, Hao Tian1, Ensheng Yao1

  • 1Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, PR China.

Scientific Reports
|August 12, 2017
PubMed

Insights

Inhibition of soluble epoxide hydrolase (sEH) with TPPU protected white matter integrity and improved cognitive function in mice with chronic cerebral hypoperfusion. This suggests sEH inhibition is a promising therapeutic strategy for white matter lesions.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Pathology

Background:

  • Chronic cerebral hypoperfusion causes white matter lesions (WMLs) linked to cognitive decline.
  • The precise mechanisms of demyelination in WMLs remain unclear.
  • Soluble epoxide hydrolase (sEH) metabolizes epoxyeicosatrienoic acids and is a potential therapeutic target.

Purpose of the Study:

  • To investigate the therapeutic potential of a potent sEH inhibitor, TPPU, in a mouse model of chronic hypoperfusion-induced WMLs.
  • To elucidate the effects of sEH inhibition on white matter pathology and cognitive function.

Main Methods:

  • Adult male C57BL/6 mice underwent bilateral carotid artery stenosis (BCAS) to induce chronic hypoperfusion and WMLs.
  • Mice were treated with the sEH inhibitor TPPU.
  • Evaluated microglia activation, inflammatory response, oligodendrogenesis, white matter integrity, remyelination, and cognitive function.

Main Results:

  • TPPU administration significantly reduced microglia activation and inflammation.
  • TPPU treatment promoted M2 microglial polarization, enhanced oligodendrogenesis, and improved oligodendrocyte differentiation.
  • White matter integrity and remyelination were promoted, leading to functional recovery and cognitive improvement.

Conclusions:

  • sEH inhibition by TPPU demonstrates multi-target protective effects against chronic hypoperfusion-induced WMLs.
  • Targeting sEH offers a promising therapeutic avenue for alleviating cognitive impairment associated with WMLs.

Related Concept Videos